文献速递肾小球疾病慢性肾脏病

重链沉积病:中国单中心病例系列的临床病理特征

Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
PubMed 文献 · Am J Kidney Dis · 2019-11-05

该研究回顾性分析中国单中心25例经活检证实的重链沉积病(HCDD)患者,平均年龄50.3岁,常见表现为高血压、水肿、贫血、肾功能不全和肾病范围蛋白尿。所有患者肾活检均显示免疫球蛋白G类重链沉积,平均随访40.1个月,化疗与肾脏生存改善相关。

要点

  • 中国HCDD患者多表现为高血压、水肿、贫血及肾功能不全。
  • 肾活检免疫荧光显示所有患者均为免疫球蛋白G类重链沉积。
  • 化疗可改善肾脏生存,尤其在疾病早期阶段。

核心结论

  • 在中国单中心HCDD病例系列中,所有患者肾活检重链沉积均为免疫球蛋白G类。
  • 化疗可改善肾功能,尤其在疾病早期阶段。

研究设计与样本

  • 回顾性病例系列,纳入25例经活检证实的HCDD患者。
  • 来自中国单中心,平均年龄50.3岁,14例男性,11例女性。

主要发现

  • 临床表现包括高血压76%、水肿96%、贫血84%、血清肌酐>1.2mg/dL占68%、肾病范围蛋白尿56%、镜下血尿80%。
  • 1例(4%)诊断为多发性骨髓瘤。
  • 21例中10例(48%)血清免疫固定电泳单克隆免疫球蛋白阳性。
  • 68%患者补体C3降低。
  • 光镜下所有患者均见结节性系膜硬化。

临床怎么用

  • 对于表现为高血压、水肿、贫血、肾功能不全及蛋白尿的患者,应考虑HCDD可能。
  • 肾活检免疫荧光是诊断HCDD的关键,需明确重链类型。
  • 化疗可能改善肾脏预后,尤其应尽早用于疾病早期患者。

局限性

  • 回顾性研究,单中心经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Heavy chain deposition disease (HCDD) is a rare consequence of monoclonal immunoglobulin deposition disease that has not been well characterized in non-white populations. To explore the clinicopathologic characteristics and outcomes of HCDD in Chinese individuals, we report on a case series assembled in a single center in China. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: 25 patients with biopsy-proven HCDD were studied retrospectively. RESULTS: 14 men and 11 women with an average age of 50.3 years were studied. The patients presented with hypertension (76%), edema (96%), anemia (84%), serum creatinine level > 1.2mg/dL (68%), nephrotic-range proteinuria (56%), and microscopic hematuria (80%). One (4%) patient had multiple myeloma diagnosed. Serum immunofixation electrophoresis showed that 10 of 21 (48%) patients were positive for monoclonal immunoglobulin. Hypocomplementemia of C3 was found in 68% of patients. Nodular mesangial sclerosis was identified in all patients by using light microscopy. Using immunofluorescence, all 25 patients had deposition of heavy chains of immunoglobulin G class (γ1, 13; γ2, 2; γ3, 6; γ4, 2; γ1 and γ4, 1; and γ2 and γ4, 1). During an average of 40.1 months of follow-up of 20 patients, 65% had improved kidney function, 10% had worsening kidney function, and 25% progressed to kidney failure. Mean values for kidney and patient survival were 37.8 and 40.1 months, respectively. Kidney survival was higher among patients who received chemotherapy. LIMITATIONS: Retrospective study, single-center experience. CONCLUSIONS: In this case series of HCDD in a single center in China, the heavy chain deposits seen in the kidney biopies of all individuals were of immunoglobulin G class. Chemotherapy improved kidney function, especially among individuals in an early stage of the disease.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Li X, Liang D, et al. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series. Am J Kidney Dis. 2019. PMID: 31699519. doi:10.1053/j.ajkd.2019.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。